Ipatasertib Market In Global
Ipatasertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (prote ... Read More
Triciribine is a potent AKT inhibitor and a cell-permeable tricyclic nucleoside molecule with potential antineoplastic activity.
This report contains market size and forecasts of Triciribine in global, including the following market information:
Global Triciribine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Triciribine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Triciribine companies in 2021 (%)
The global Triciribine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Triciribine include Adooq Bioscience, Selleck Chemicals, Santa Cruz Biotechnology, Enzo Biochem, Biosynth Carbosynth, Abcam, Bio-Techne, BOC Sciences and LGC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Triciribine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Triciribine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triciribine Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Triciribine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triciribine Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Triciribine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triciribine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Triciribine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Triciribine revenues share in global market, 2021 (%)
Key companies Triciribine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Triciribine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adooq Bioscience
Selleck Chemicals
Santa Cruz Biotechnology
Enzo Biochem
Biosynth Carbosynth
Abcam
Bio-Techne
BOC Sciences
LGC
Clearsynth
Taiclone
Cayman Chemical
Merck
Aladdin
Ipatasertib is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (prote ... Read More
Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of ... Read More
2-Methyl-2-Pentenoic Acid is a carboxylic acid with the molecular formula C6H10O2, it is found in ... Read More
Buparlisib is an orally bioavailable and selective pan-class I phosphatidylinositol-3 kinase (PI3 ... Read More